ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2310

Machine Learning Approaches for Prediction of Renal Flares in Systemic Lupus Erythematosus: Knowledge-Driven Models Outperformed Data-Driven Models

Nursen Cetrez1, Julius Lindblom1, Raffaele Da Mutten2, Dionysis Nikolopoulos2 and Ioannis Parodis1, 1Karolinska Institutet, Stockholm, Sweden, 2Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, B-Cell Targets, Biostatistics, Lupus nephritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Renal flares in patients with SLE result in significant nephron loss. Thus, identification of reliable early signals of impending renal flares is anticipated to improve the prognosis for these patients. Machine learning (ML) has witnessed growing utilisation in managing extensive, heterogeneous datasets, and non-linear relationships. In this study, we implemented two different approaches of ML algorithms to identify baseline clinical and laboratory determinants of renal flare occurrence in a large cohort of SLE.

Methods: We analysed data from five phase III trials (BLISS-52, BLISS-76, BLISS-NEA, BLISS-SC, EMBRACE) after exclusion of patients with baseline renal flare BILAG A or B (N=3169). Renal flares were defined as a change from C, D, or E to A or B in the renal domain of the classic BILAG index within a 52-week long follow-up. Following construction of panels of variables using either (i) knowledge or (ii) feature selection methods, we developed ML classifiers including extreme gradient boosting (XGBoost), least absolute shrinkage and selection operator (LASSO), random forest (RF), and multivariable logistic regression. A stratified split was applied to the data to partition the study population into a training (90%; N=2853) and a test set (10%; N=316). The training set was used in model development while the internal validation was developed by a 10 times 10-fold cross validation. The test set was used for external validation of the built model, and the performance of the models was demonstrated using area under the curve (AUC) of the receiver operating curves (ROC), accuracy with a 95% confidence interval (CI), sensitivity, and specificity metrics.Both approaches yielded final models that utilised the minimal number of features while maintaining optimal model performance.

Results: Of 3169 patients, 899 (28.3%) developed a renal flare during follow-up. XGBoost yielded the greatest accuracy both in the hypothesis-driven (0.97 and the data-driven approach (0.88), as well as the highest performance metrics (AUC: 0.97 and 0.91; sensitivity: 1.00 and 0.82; specificity: 0.94 and 0.94, respectively) and an adequate calibration on the test dataset. LASSO (accuracy: 0.95 and 0.86 ; AUC: 0.97 and 0.96; sensitivity: 1.00 and 0.86; specificity: 0.91 and 0.86, respectively) demonstrated similar performance. The final model successfully reduced the number of features to five parameters: renal BILAG C or D score, urine protein creatinine ratio, serum albumin, blood urea nitrogen, and C3 levels. These models exhibited encouraging performance, with AUC values of 0.88, 0.88, 0.88, and 0.87 for XGBoost, LASSO, logistic regression, and RF, respectively.

Conclusion: The knowledge-driven approach based on clinical expertise outperformed the unsupervised data-driven approach which solely relied on feature selection methods. Through utilisation of five routine clinical parameters, we developed a robust and highly accurate prediction tool for forecasting renal flares in patients with SLE. Our ML-based model holds substantial value in guiding clinical decision-making to personalise patient management and possesses potential for practical application in clinical settings.


Disclosures: N. Cetrez: None; J. Lindblom: None; R. Da Mutten: None; D. Nikolopoulos: None; I. Parodis: Amgen, 5, 6, AstraZeneca, 5, 6, Aurinia Pharmaceuticals, 5, 6, Bristol-Myers Squibb(BMS), 5, 6, Elli Lilly and Company, 5, 6, F. Hoffmann-La Roche AG, 5, 6, Gilead Sciences, 5, 6, GSK, 5, 6, Janssen Pharmaceuticals, 5, 6, Novartis, 5, 6, Otsuka Pharmaceutical, 5, 6.

To cite this abstract in AMA style:

Cetrez N, Lindblom J, Da Mutten R, Nikolopoulos D, Parodis I. Machine Learning Approaches for Prediction of Renal Flares in Systemic Lupus Erythematosus: Knowledge-Driven Models Outperformed Data-Driven Models [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/machine-learning-approaches-for-prediction-of-renal-flares-in-systemic-lupus-erythematosus-knowledge-driven-models-outperformed-data-driven-models/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/machine-learning-approaches-for-prediction-of-renal-flares-in-systemic-lupus-erythematosus-knowledge-driven-models-outperformed-data-driven-models/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology